Added to YB: 2022-02-18
Pitch date: 2022-02-18
AMPH [bearish]
Amphastar Pharmaceuticals, Inc.
-0.23%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
Market Cap
$1.3B
Pitch Price
$26.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.42
P/E
8.70
EV/Sales
2.32
Sector
Pharmaceuticals
Category
N/A
Show full summary:
AMPHASTAR PHARMACEUTICALS INC AMPH
A summary for this pitch has not been created yet.
Read full article (0 min)